Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 55 min ago
Peer-reviewedCC BYBMJ open

Cost-utility analysis and budget impact of policy options for kidney replacement therapy coverage for end-stage kidney disease in Kenya.

  • Patricia Nyokabi1,2
  • Usa Chaikledkaew3,4,5
  • Montarat Thavorncharoensap1,4,5
  • Sitaporn Youngkong1,4,5
  • Nyamai Mutono2,6
  • Grace Ngaruiya7
  • Ammarin Thakkinstian1,8
8 affiliations
  1. 1Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Bangkok, Thailand.
  2. 2Center for Epidemiological Modelling and Analysis, University of Nairobi, Nairobi, Kenya.
  3. 3Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Bangkok, Thailand [email protected].
  4. 4Social Administrative Pharmacy Division, Department of Pharmacy, Mahidol University, Faculty of Pharmacy, Bangkok, Thailand.
  5. 5Global Health Technology Assessment (GHTA) Research Center, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
  6. 6Paul G Allen School for Global Animal Health, Washington State University, Pullman, Washington, USA.
  7. 7School of Public Health, University of Nairobi, Nairobi, Kenya.
  8. 8Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Read full textPDFDOICite

Related

  1. Financing assistive technology—Policy options on the path towards universal health coverage
    Jens Wilkens, Ranjavati Banerji, Satish Mishra
    Frontiers in public healthPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  2. GLP-1 Receptor Agonists and Risk of Kidney Replacement Therapy and Healthcare Utilization in Bipolar Disorder with Chronic Kidney Disease
    Balwinder Singh, Maria L Gonzalez Suarez, Hossam M Ali +1
    The Journal of clinical psychiatryPeer-reviewedLicence not statedFull textEndocrinology & metabolismPMC
  3. Dopamine replacement therapy modulates DDC, prolactin and AOC3 levels in Parkinson’s disease
    Ludo van Hillegondsberg, Shahzad Ahmad, Tanja Zerenner +10
    NPJ Parkinson's DiseasePeer-reviewedCC BY 4.0Full textNeurologyPMC
  4. Menopause and Alzheimer’s disease: can hormone replacement therapy modify the risk? A narrative review
    Jenny Y Wang, Olaf Ansorge
    BMC Women's HealthPeer-reviewedCC BY-NC-ND 4.0Full textEndocrinology & metabolismPMC
  5. Testosterone, Testosterone Replacement Therapy, and Cardiovascular Disease: A Contemporary Review
    Anand Reddy Maligireddy, Shumedha T. Barua, Rajat S. Barua
    Journal of the American Heart AssociationPeer-reviewedCC BY-NC-NDEndocrinology & metabolismCrossref

Cite

BibTeXRIS
BibTeX
@article{nyokabi2026costutility,
  title = {{Cost-utility analysis and budget impact of policy options for kidney replacement therapy coverage for end-stage kidney disease in Kenya.}},
  author = {Patricia Nyokabi and Usa Chaikledkaew and Montarat Thavorncharoensap and Sitaporn Youngkong and Nyamai Mutono and Grace Ngaruiya and Ammarin Thakkinstian},
  journal = {BMJ open},
  year = {2026},
  month = oct,
  doi = {10.1136/bmjopen-2026-123693},
  url = {https://europepmc.org/article/MED/42880800},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Cost-utility analysis and budget impact of policy options for kidney replacement therapy coverage for end-stage kidney disease in Kenya.
AU  - Patricia Nyokabi
AU  - Usa Chaikledkaew
AU  - Montarat Thavorncharoensap
AU  - Sitaporn Youngkong
AU  - Nyamai Mutono
AU  - Grace Ngaruiya
AU  - Ammarin Thakkinstian
PY  - 2026
DA  - 2026/10/14
JO  - BMJ open
DO  - 10.1136/bmjopen-2026-123693
UR  - https://europepmc.org/article/MED/42880800
SN  - 2044-6055
ER  -